Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
Authors:
- E.A HøibyEHE.A Høiby
- J.K GrønnesbyJGJ.K Grønnesby
- Ø ArnesenØAØ Arnesen
- J.H FredriksenJFJ.H Fredriksen
- A-K LindbakALA-K Lindbak
- H NøklebyHNH Nøkleby
- E RosenqvistERE Rosenqvist
- L.K SolbergLSL.K Solberg
- O ClossOCO Closs
- L.O FrøholmLFL.O Frøholm
- A LystadALA Lystad
- 1 November 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 338 (8775) , 1093-1096
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Vaccines for prevention of meningococcal diseaseClinical Microbiology Reviews, 1989
- Phenoxymethyl-penicillin treatment of household contacts of meningococcal disease patientsAntonie van Leeuwenhoek, 1986
- Meningococcal disease in NorwayAntonie van Leeuwenhoek, 1986
- ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITISThe Lancet, 1983
- Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in ManJournal of Clinical Investigation, 1979